SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-034879
Filing Date
2018-06-19
Accepted
2018-06-19 21:00:21
Documents
1
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv496818_3.html 3  
1 OWNERSHIP DOCUMENT tv496818_3.xml 3 6831
  Complete submission text file 0001144204-18-034879.txt   9339
Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38533 | Film No.: 18908505

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38533 | Film No.: 18908503

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38533 | Film No.: 18908504

Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Issuer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations